Clinical Study

Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections

Table 2

Comparison of laboratory findings before and after treatment.

Before treatmentAfter treatment value

White blood cell count (103/mm3)5.849 ± 1.5155.891 ± 1.4240.753
Hemoglobin (g/dL)14.040 ± 1.28813.928 ± 1.24090.123
Platelet count (103/mm3)228.33 ± 42.698222.11 ± 41.6330.054
Total protein (g/dL)7.224 ± 0.3867.230 ± 0.3260.868
Albumin (g/dL)4.506 ± 0.2994.578 ± 0.2680.025
Total bilirubin (mg/dL)0.773 ± 0.4480.750 ± 0.5520.308
Aspartate transaminase (IU/L)22.33 ± 4.86222.70 ± 6.0530.580
Alanine transaminase (IU/L)21.95 ± 8.96822.78 ± 10.6240.472
Alkaline phosphatase (IU/L)61.105 ± 16.44862.150 ± 16.6130.503
γ-Glutamyl transpeptidase (IU/L)22.09 ± 15.69322.70 ± 13.7560.063
Blood urea nitrogen (mg/dL)13.620 ± 3.47513.694 ± 3.3760.863
Creatinine (mg/dL)0.781 ± 0.1730.755 ± 0.1630.008
Glucose (mg/dL)101.31 ± 13.39299.95 ± 12.8490.139
Total cholesterol (mg/dL)200.14 ± 34.964195.49 ± 30.8200.185
Triglyceride (mg/dL)133.56 ± 80.728128.68 ± 80.5980.462

.